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Cardiovascular diseases are still the most 
common cause of death in Germany. In 
recent years, however, a clear reduction 
in the mortality rates due to cardiovascu-
lar diseases (ICD-10: I00-I99) can be not-
ed [1]. A decrease in mortality due to cor-
onary heart disease (CHD) is the main 
cause for this development [2]. Parallel 
trends can be observed in numerous oth-
er high-income countries and are mainly 
explained by a reduction in the prevalence 
of classical risk factors—hypertension, hy-
percholesterolemia and smoking—as well 
as by improved therapeutic options in the 
treatment of acute myocardial infarction 
and in secondary prevention [3, 4, 5, 6, 7, 
8, 9, 10].
In Germany, data on trends in inci-
dence, treatment and outcome of myocar-
dial infarction are available from the re-
gional population-based myocardial in-
farction register of the Cooperative Health 
Research in the Region of Augsburg (KO-
RA) which is part of the WHO MONICA 
Project. According to this study, the inci-
dence of myocardial infarction has fallen 
continuously in the last 20 years and acute 
infarctions are treated faster and in better 
compliance with guideline recommenda-
tions, leading to lower case fatality [11, 12].
From a public health point of view, 
the question arises as to how high the 
prevalence of survived myocardial in-
farction and coronary heart disease cur-
rently is. This measure provides infor-
mation on the percentage of the popula-
tion that must be provided with second-
ary-preventive measures, specific ther-
apies or rehabilitative and care services. 
It is possible to further reduce the inci-
dence of myocardial infarction, if coro-
nary heart disease is diagnosed in time 
and guideline therapies and measures 
to reduce relevant risk factors are ini-
tiated. Furthermore the consequenc-
es of myocardial infarction can be min-
imised through timely diagnosis and in-
vasive therapy to re-establish circulation 
in the heart muscle. At best, an infarc-
tion can be survived without any signifi-
cant sequelae. If however, extensive dam-
age to the heart muscle results, myocar-
dial infarction can also lead to severely 
impaired pump function and heart fail-
ure. In-patient and out-patient therapy of 
patients with heart failure accounts for a 
significant and increasing percentage of 
the health care provided by health insur-
ance funds [13, 14].
This article presents findings from the 
first wave of the German Health Inter-
view and Examination Survey for Adults 
(DEGS1) regarding the prevalence of 
myocardial infarction and coronary heart 
disease in adults aged 40–79 years in Ger-
many and analyses the trend in prevalence 
since the German National Health Inter-
view and Examination Survey 1998 (GN-
HIES98) [15].
Methods
Study design and sample
The German Health Interview and Exam-
ination Survey for Adults (“Studie zur Ge-
sundheit Erwachsener in Deutschland”, 
DEGS) is part of the health monitoring 
system at the Robert Koch Institute (RKI). 
The concept and design of DEGS are de-
scribed in detail elsewhere [16, 17, 18, 19, 
20]. The first wave (DEGS1) was conduct-
ed from 2008–2011 and comprised inter-
views, examinations and tests [21, 22]. The 
target population comprises the residents 
of Germany aged 18–79 years. DEGS1 
has a mixed design, which permits both 
cross-sectional and longitudinal analyses. 
For this purpose, a random sample from 
local population registries was drawn to 
supplement former participants from the 
German National Health Interview and 
Examination Survey 1998 (GNHIES98). A 
total of 8,152 people participated, includ-
ing 4,193 first-time participants (response 
rate 42%) and 3,959 revisiting participants 
of GNHIES98 (response rate 62%). A to-
tal of 7,238 persons attended one of the 
180 examination centres, and 914 were in-
terviewed only. The net sample [20] per-
mits representative cross-sectional analy-
ses for the age range 18–79 years (n=7,988, 
including 7,116 in study centres) and time 
trend analyses based on comparison with 
GNHIES98. The analyses presented here 





Data was collected by a standardised com-
puter-assisted interview conducted by a 
physician and by a self-completion ques-
tionnaire on health-relevant indicators. In 
detail, the participants were asked wheth-
er coronary heart disease had ever been 
diagnosed by a physician using the fol-
lowing questions: “Has a doctor ever di-
agnosed you as having had a myocardi-
al infarction?” or “Has a doctor ever di-
agnosed you as having an impaired blood 
supply to the heart, narrowing of the cor-
onary arteries or angina pectoris?” To es-
tablish the lifetime prevalence of a coro-
nary heart disease, self-reported preva-
lence of myocardial infarction and of an-
gina pectoris or other coronary heart dis-
order were summarised.
Socioeconomic status was deter-
mined using an index which includes 
information on school education and 
vocational training, professional status 
and net household income (weighted 
by household needs) permitting classi-
fication into low, middle and high sta-
tus groups [23].
Statistical analysis
The lifetime prevalence of myocardial in-
farction and of angina pectoris or oth-
er coronary heart disorder was calculat-
ed as the proportion of participants an-
swering “Yes” of the total number of par-
ticipants with valid “Yes” or “No” answers 
and expressed as a percentage with 95% 
confidence intervals (95% CI). Partici-
pants who gave no answer or an answer 
of “Don’t know” were excluded from the 
respective analyses.
The cross-sectional analyses on life-
time prevalence in DEGS1 were carried 
out using a weighting factor, which cor-
rects sample deviations from population 
structure (as of 31 Dec 2010) with re-
gard to age, sex, region and nationality, 
as well as type of community and educa-
tion [20]. When calculating the weight-
ing factor for previous participants of 
GNHIES98, the probability of repeated 
participation, based on a logistic model, 
was taken into account. A non-responder 
analysis and the comparison of selected 
indicators with data from official statis-
tical sources indicate a high level of sam-
ple representativeness for the residential 
population in Germany [20].
Tab. 1 Lifetime prevalence of coronary heart disease (CHD), myocardial infarction, angina pectoris or other CHD in adults aged 40–79 years in 
DEGS1 by age and sex
  40–49 years 50–59 years 60–69 years 70–79 years Overall
  % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
CHD overall
Women (n=3,037) 1.6 (0.7–3.5) 1.8 (0.9–3.2) 10.8 (8.3–13.9) 15.5 (12.2–19.4) 6.4 (5.4–7.6)
Men (n=2,745) 3.0 (1.6–5.6) 6.9 (4.9–9.8) 19.5 (15.9–23.7) 30.5 (25.9–35.5) 12.3 (10.8–14.0)
Overall (n=5,782) 2.3 (1.4–3.8) 4.4 (3.2–5.9) 15.1 (12.8–17.7) 22.3 (19.3–25.5) 9.3 (8.4–10.3)
Myocardial infarction
Women (n=3,073) 0.6 (0.2–2.5) 0.1 (0.0–0.7) 4.7 (2.8–7.6) 6.0 (3.9–9.2) 2.5 (1.8–3.4)
Men (n=2,766) 2.3 (1.1–4.9) 3.8 (2.5–5.8) 11.9 (8.7–16.0) 15.3 (11.6–19.9) 7.0 (5.8–8.4)
Overall (n=5,389) 1.5 (0.8–2.9) 2.0 (1.3–3.0) 8.2 (6.2–10.7) 10.2 (8.0–12.8) 4.7 (4.0–5.5)
Angina pectoris/other CHD
Women (n=3,040) 1.6 (0.7–3.5) 1.8 (0.9–3.2) 9.1 (6.9–12.0) 13.8 (10.7–17.6) 5.7 (4.7–6.8)
Men (n=2,744) 2.2 (1.1–4.4) 6.4 (4.3–9.2) 15.2 (12.3–18.6) 27.3 (22.8–32.2) 10.4 (9.1–12.0)
Overall (n=5,784) 1.9 (1.1–3.2) 4.1 (2.9–5.6) 12.1 (10.2–14.4) 19.9 (17.1–23.1) 8.0 (7.2–9.0)
Tab. 2 Temporal trends in the lifetime prevalence of coronary heart disease (CHD), myocardial infarction and angina pectoris (AP) or other CHD 
in adults aged 40–79 years comparing DEGS1 (n=5,901) and GNHIES98 (n=4,285) by sex
  GNHIES98a GNHIES98, age-adjustedb DEGS1b Change Change, age-adjusted
 % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
Women
CHD overall 8.9 (7.4–10.6) 8.7 (7.2–10.6) 6.4 (5.4–7.6) −2.5 (−4.4; −0.6) −2.3 (−4.3; −0.4)
Myocardial infarction 2.4 (1.7–3.2) 2.3 (1.7–3.2) 2.5 (1.8–3.4) +0.1 (−0.9; +1.1) +0.2 (−0.09; +1.2)
AP/other CHD 8.4 (7.0–10.1) 8.3 (6.9–10.0) 5.7 (4.7–6.8) −2.7 (−4.5; −0.9) −2.6 (−4.5; −0.7)
Men
CHD overall 12.1 (10.8–13.6) 12.7 (11.2–14.3) 12.3 (10.8–14.0) +0.2 (−0.18; +2.3) −0.4 (−2.5; +1.8)
Myocardial infarction 5.3 (4.4–6.4) 5.7 (4.7–7.0) 7.0 (5.8–8.4) +1.7 (+0.2; +3.2) +1.3 (−0.4; +2.9)
AP/other CHD 10.8 (9.5–12.3) 11.2 (9.8–12.8) 10.4 (9.1–12.0) −0.4 (−2.3; +1.5) −0.8 (−2.8; +1.2)
Overall
CHD overall 10.4 (9.3–11.7) 10.7 (9.5–12.0) 9.3 (8.4–10.3) −1.1 (−2.6; +0.4) −1.4 (−2.9; +0.2)
Myocardial infarction 3.8 (3.1–4.5) 4.0 (3.3–4.8) 4.7 (4.0–5.5) +0.9 (0.0; +1.9) +0.7 (−0.3; +1.7)
AP/other CHD 9.6 (8.5–10.7) 9.7 (8.6–11.0) 8.0 (7.2–9.0) −1.6 (−2.9; −0.1) −1.7 (−3.2; −0.2)
aAdjusted to population structure as of 31 Dec 1997 bAdjusted to population structure as of 31 Dec 2010.
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Main topic
For the analyses of temporal trends, 
lifetime prevalence in DEGS1 was com-
pared with prevalence data in the German 
National Health Interview and Examina-
tion Survey 1998 (GNHIES98). To this 
end, the prevalence figures of GNHIES98 
were re-calculated using the new method-
ology of weighting developed in DEGS1. 
In the course of this the GNHIES98 sam-
ple was adjusted to the population struc-
ture as of 31 Dec 1997 by weighting the re-
sults for age, sex, region, nationality, com-
munity type and education [17]. In order 
to take the demographic changes in pop-
ulation structure since GNHIES98 in-
to account, in a second step of the trend 
analysis, the GNHIES98 data was age-ad-
justed to the population structure as of 
31 Dec 2010.
In order to take into account both the 
weighting and the correlation of the par-
ticipants within a community, the confi-
dence intervals for all analyses were de-
termined using the survey procedures in 
Stata 12.1 and SAS 9.3 [24]. Differences are 
deemed to be statistically significant if the 
respective 95% confidence intervals of the 
prevalence estimators do not overlap.
Results
Myocardial infarction
The lifetime prevalence of physician-di-
agnosed, myocardial infarction in the age 
group 40–79 years is 4.7%. An increase in 
prevalence can be observed with advanc-
ing age, from 1.5% in 40–49 year olds to 
10.2% in 70–79 year olds. In women, prev-
alence at 2.5% is less than half of that in 
men at 7.0% and prevalence is less than 1% 
below age 60 years (. Tab. 1).
The comparison between GNHIES98 
and DEGS1 reveals an absolute increase 
in the prevalence of myocardial infarction 
from 3.8 to 4.7%. This development is al-
most entirely attributable to an increase in 
the prevalence in men (+1.7%). No statisti-
cally significant change is found in wom-
en. Comparing the lifetime prevalence of 
myocardial infarction in GNHIES98 after 
age adjustment to the population struc-
ture of 31 Dec 2010 to that in DEGS1, there 
are no statistically significant differences, 
neither overall nor within both sexes sep-
arately (. Tab. 2).
Coronary heart disease
Summarised under the term “coronary 
heart disease” (CHD) are myocardial in-
farction and angina pectoris as well as oth-
er manifestations of coronary heart dis-
ease.
The lifetime prevalence of coronary 
heart disease in the age group 40–79 years 
is 9.3% overall. Prevalence increases—
with sex-specific variations—with in-
creasing age. In women, prevalence at 
6.4% is about half as high as that of men 
at 12.3% (. Tab. 1).
Compared to GNHIES98, both overall 
and among men alone there is no statisti-
cally significant change in the prevalence 
either in the raw data or in the age-adjust-
ed data. In women, there is a reduction in 
prevalence of coronary heart disease from 
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Prevalence of myocardial infarction and coronary heart disease 
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Abstract
In the German Health Interview and Exami-
nation Survey for Adults (DEGS1), data on the 
prevalence of myocardial infarction and coro-
nary heart disease were collected from 2008–
2011 in a representative population-based 
sample of 5,901 adults aged 40–79 years. The 
results of DEGS1 were compared with the 
prevalence estimates from the German Na-
tional Health Interview and Examination Sur-
vey 1998 (GNHIES98). The lifetime prevalence 
of myocardial infarction amongst 40–79 year 
olds in DEGS1 is 4.7% (women 2.5%; men 
7%). In comparison with GNHIES98 a small in-
crease was observed in men, but not in wom-
en. The lifetime prevalence of coronary heart 
disease in adults aged 40–79years in DEGS1 
is 9.3% (women 6.4%; men 12.3%). In com-
parison to GNHIES98 there is a slight reduc-
tion only in women. There is a significant in-
verse relationship between disease preva-
lence and socioeconomic status. The trend in 
prevalence of coronary heart disease is com-
parable with that in other high-income coun-
tries. Given a falling incidence of myocardi-
al infarction and a decrease in the mortality 
rates due to coronary heart disease, the basi-
cally stable prevalence rates indicate a posi-
tive development in the field of cardiovascu-
lar prevention and therapy.
Keywords
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Prävalenz von Herzinfarkt und koronarer Herzkrankheit bei 
Erwachsenen im Alter von 40 bis 79 Jahren in Deutschland.  
Ergebnisse der Studie zur Gesundheit Erwachsener in  
Deutschland (DEGS1)
Zusammenfassung
In der Studie zur Gesundheit Erwachsener 
in Deutschland (DEGS1) wurden von 2008 
bis 2011 in einer bevölkerungsrepräsenta-
tiven Stichprobe von 5901 Personen in der 
Altersgruppe von 40 bis 79 Jahren Daten 
zur Prävalenz von Herzinfarkt und koronarer 
Herzkrankheit erhoben. Die Ergebnisse von 
DEGS1 wurden mit denen aus dem Bundes-
Gesundheitssurveys 1998 (BGS98) verglichen. 
Die Lebenszeitprävalenz des Herzinfarktes 
bei 40- bis 79-Jährigen in DEGS beträgt 4,7% 
(Frauen 2,5%; Männer 7%). Im Vergleich 
zum BGS98 zeigte sich ein geringer Anstieg 
bei Männern, nicht jedoch bei Frauen. Die 
Lebens zeitprävalenz der koronaren Herz-
krankheit bei 40- bis 79-Jährigen beträgt in 
DEGS1 9,3% (Frauen 6,4%; Männer 12,3%). 
Im Vergleich zum BGS98 ergibt sich nur bei 
Frauen eine geringe Abnahme. Es besteht 
ein signifikanter inverser Zusammenhang 
zwischen Erkrankungshäufigkeit und Sozial-
status. Die Entwicklung der Prävalenzen der 
koronaren Herzkrankheit ist vergleichbar mit 
der in anderen industrialisierten Ländern. Bei 
sinkender Inzidenz des Herzinfarktes und ei-
nem Rückgang der Mortalitätsraten aufgrund 
koronarer Herzkrankheit spricht die im We-
sentlichen gleichbleibende Prävalenz für eine 
positive Entwicklung im Bereich der kardio-
vaskulären Prävention und Therapie.
Schlüsselwörter
Koronare Herzkrankheit · Herzinfarkt ·  
Prävalenz · Gesundheitssurvey
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8.9 to 6.4%. In the age-standardised com-
parison of DEGS1 and GNHIES98 there 
is an absolute fall in prevalence of 2.3% 
(. Tab. 2). The reduction in prevalence 
can primarily be attributed to a reduction 
in angina pectoris and/or other manifes-
tations of coronary heart disease amongst 
older women (data not shown in detail).
The lifetime prevalence of coronary 
heart disease both overall and in men 
and women separately is highest in per-
sons of low socioeconomic status and 
vice versa. This observation is also true 
for most age and sex-specific subgroups, 
but not in the highest age group overall 
and in men. The social gradient in gen-




The lifetime prevalence of myocardial in-
farction in DEGS1 agrees well with the 
results of the telephone survey German 
Health Update (GEDA 2010) which was 
conducted by the RKI at the same time 
with the same wording of questions for 
disease prevalence [25]. In this the prev-
alence for both genders in the age group 
40–79 years were 4.5% overall, for women 
2.3% and for men 6.9% (own calculations 
for the age group 40–79 years). The valid-
ity of self-reports of diagnosed myocardi-
al infarction is likely to be very high. Any 
such event would be well-remembered by 
the person affected since it is generally ac-
companied by severe pain and emergency 
treatment [30].
Compared with GNHIES98 a small in-
crease in the crude prevalence of survived 
myocardial infarction of 0.9% is evident, 
which can be attributed to a statistically 
significant increase amongst men (+1.7%). 
In the age-adjusted analysis this increase 
is no longer found and thus the increase in 
the crude prevalence can at least in part be 
explained by the demographic ageing of 
the population. One further reason for the 
increase in crude lifetime prevalence, giv-
en falling incidence of myocardial infarc-
tion, is the fact that persons having myo-
cardial infarctions are more likely to sur-
vive longer due to improved therapeutic 
possibilities [11, 12].
The lifetime prevalence in DEGS1 and 
the small changes over time is compara-
ble with current data from England and 
the USA. In the Health Survey for Eng-
land (HSE) [26] and in the United States’ 
National Health and Nutrition Examina-
tion Survey (NHANES) [5] the prevalence 
of myocardial infarction and angina pec-
toris were established in a manner simi-
lar to DEGS1 on the basis of self-reports 
regarding physician-diagnosed illnesses. 
For the year 2006, the prevalence of myo-
cardial infarction reported from Eng-
land was 1.7% in women and 4.1% in men 
[26]. For the period 1994–2006 no rele-
vant changes were reported for either sex; 
in the older age group, however, a gradual 
increase was reported for both sexes [27]. 
For the USA—based on the NHANES da-
ta from 2008—a lifetime prevalence of 
3.1% (women 2.2%; men 4.3%) was re-
ported [5]. For the period from 1999–2008 
in adults aged 25–74 years, a reduction in 
prevalence of myocardial infarction was 
observed in men, and no relevant change 
in women [28].
Coronary heart disease
The lifetime prevalence of coronary heart 
disease in DEGS1 compared to GN-
HIES98 shows a reduction of 1.1% in the 
crude analysis. The decrease is primarily 
due to a reduction in prevalence of angina 
pectoris and other coronary heart diseases 
from 8.4 to 5.7% in women. The reduction 
remains virtually unchanged in the age-
adjusted analysis and therefore is not ex-
plained by the changed age structure.
Data from the telephone survey Ger-
man Health Update (GEDA 2010), which 
was conducted at the same time as DEGS1, 
show a slightly higher prevalence at 10.6% 
overall (women 8.0%; men 13.4%; own 
calculations for the age group 40–79 
years) [25]. This difference can possibly be 
explained by differential response behav-
iour in face-to-face interviews by study 
doctors in DEGS1 compared to telephone 
interviews by trained lay interviewers in 
GEDA. The validity of self-reported coro-
nary heart disease is known to be less pro-
nounced than that of myocardial infarc-
tion, since this diagnosis is not as clearly 
defined for a lay person [29, 30].
In the Health Survey for England 2006, 
a CHD prevalence of 5.2% was reported 
(women 4.0%; men 6.5%) with no change 
in overall prevalence over time, only the 
oldest age group (75 and over) showed a 
small increase in both sexes [26]. In the 
USA, on the basis of the NHANES data 
from 2008, the prevalence of CHD was es-
tablished as 7% (women 6.1%; men 8.3%) 
[5]. In the annual telephone survey in the 
USA (the Behavioral Risk Factor Surveil-
lance System) a reduction in the lifetime 
prevalence was evident. In the period be-
tween 2006 and 2010 a decrease of 0.7% 
is reported and this decrease is more pro-
nounced amongst women than men [31].
The higher prevalence of myocardial 
infarction and CHD in Germany, in com-
parison with the aforementioned coun-
tries, can primarily be explained by the 
fact that within the German population, 
Tab. 3 Lifetime prevalence of coronary heart disease (CHD) overall in DEGS1 by age, sex and 
socioeconomic status (low, medium or high)
  40–49 years 50–59 years 60–69 years 70–79 years Overall
  % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
Women (n=3,037)
Low 4.7 (1.5–13.4) – 15.5 (8.7–26.1) 16.0 (10.4–23.8) 10.0 (7.2–13.7)
Medium 1.4 (0.4–4.4) 2.4 (1.2–4.8) 9.8 (6.9–13.7) 15.5 (11.1–21.2) 6.2 (4.8–7.8)
High 0.3 (0.0–2.4) 1.1 (0.3–4.3) 8.0 (3.8–15.7) 8.7 (4.0–17.8) 2.7 (1.7–4.4)
Men (n=2,745)
Low 6.6 (2.3–17.6) 11.6 (6.2–20.4) 27.1 (16.1–42.0) 34.3 (22.9–47.9) 17.9 (13.5–23.2)
Medium 2.7 (1.3–5.7) 6.8 (4.1–11.0) 17.9 (13.8–22.8) 29.4 (23.8–35.6) 11.8 (9.9–14.0)
High 1.3 (0.3–6.8) 2.9 (1.3–6.2) 18.2 (12.2–26.2) 30.3 (21.0–41.4) 9.2 (7.0–12.1)
Overall (n=5,782)
Low 5.7 (2.7–11.8) 6.5 (3.4–11.8) 20.7 (13.7–30.1) 22.5 (16.6–29.7) 13.7 (11.1–16.9)
Medium 2.0 (1.0–3.8) 4.5 (3.0–6.8) 13.5 (10.9–16.5) 21.9 (18.0–26.4) 8.8 (7.6–10.2)




the proportion of those in the age group 
65 and over at 20.4% is significantly high-
er than in the United Kingdom (16.6%) 
and in the USA (13.1%) [32]. Apart from 
this, considerably higher mortality rates 
from coronary heart disease are record-
ed in the USA than in Germany. They are 
approximately 50% higher in women and 
about 20% higher in men [5]. In addition, 
national differences in the prevalence of 
cardiovascular risk factors need to be tak-
en into account [33].
The decrease in the prevalence of cor-
onary heart disease amongst women by 
2.3% is surprising. Sex-specific differences 
in the prevalence of myocardial infarction 
and coronary heart disease are known 
and attributable to biological factors, dif-
ferences in health behaviour, as well as to 
aspects of medical care. These factors al-
so influence case fatality rates in men and 
women [34]. However, as more attention 
has been paid to diagnosis and treatment 
of coronary heart disease amongst wom-
en in the past 10 years [35, 36, 37], it is un-
likely that the disease was diagnosed more 
rarely in women over time or that it is less 
perceived by them. Further analyses will 
have to show to what extent sex-specif-
ic differences in cardiovascular risk pro-
files may explain this selective reduction 
of prevalence amongst women.
Socioeconomic status
Lifetime prevalence of coronary heart 
disease is inversely associated with socio-
economic status both in women and in 
men—the higher the socioeconomic sta-
tus, the lower the prevalence. This con-
nection is well documented in literature 
and is not solely attributable to the known 
social class-specific differences in health 
behaviour [38, 39]. Psychosocial factors as 
well as working and living conditions play 
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